Teng, C. J., Liao, Y., Liao, B. (2025). Acalabrutinib versus venetoclax plus obinutuzumab in treatment-naive chronic lymphocytic leukemia: A real-world propensity score-matched study. Blood. https://doi.org/10.1182/blood-2025-5662